Who are Low Sodium Oxybate's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/low-sodium-oxybate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-21 · How we verify

Low Sodium Oxybate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Low Sodium Oxybate (Low Sodium Oxybate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: GHB receptor agonist / GABA-B receptor agonist. Area: Neurology.

marketed GHB receptor agonist / GABA-B receptor agonist GHB receptor, GABA-B receptor Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Low Sodium Oxybate (Low Sodium Oxybate) — Leiden University Medical Center. Low sodium oxybate is a reduced-sodium formulation of sodium oxybate that enhances GABAergic and GHB receptor signaling in the central nervous system to reduce excessive daytime sleepiness and cataplexy.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Low Sodium Oxybate TARGET	Low Sodium Oxybate	Leiden University Medical Center	marketed	GHB receptor agonist / GABA-B receptor agonist	GHB receptor, GABA-B receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (GHB receptor agonist / GABA-B receptor agonist class)

Leiden University Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Low Sodium Oxybate — Competitive Intelligence Brief. https://druglandscape.com/ci/low-sodium-oxybate. Accessed 2026-05-21.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab